1. Bialer, M. and White, H.S., Key factors in the discovery and development of new antiepileptic drugs, Nat. Rev. Drug Discov., 2010, vol. 9, pp. 68–82.
2. Loscher, W., Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs, Seizure, 2011, vol. 20, pp. 359–368.
3. Lukomskaya, N.Ia., Vataev, S.I., Zhabko, E.P., and Magazanik, L.G., Effects of ionotropic glutamate receptor channel blockers on the development of audiogenic seizures in Krushinski-Molodkina rats, Ross. Fiziol. Zhurn. im. Sechenova, 2012, vol. 98, pp. 449–460.
4. Lukomskaya, N.Ia., Rukoiatkina, N.I., Gorbunova, L.V., Gmiro, V.E., Bol’shakov, K.V., and Magazanik, L.G., Comparison of the anticonvulsant activity of organic mono- and di-cations and their potential to inhibit NMDA and AMPA glutamate receptors, Ross. Fiziol. Zh. im. Sechenova, 2002, vol. 88, pp. 1161–1171.
5. Lukomskaya, N.Ia., Rukoiatkina, N.I., Gorbunova, L.V., Gmiro, V.E., and Magazanik, L.G., Role of NMDA and AMPA glutamate receptors in the mechanism of corazol-induced convulsions in mice, Ross. Fiziol. Zh. im. Sechenova, 2003, vol. 89, pp. 292–301.